Philips' direct-to-angio stroke pathway: new analysis demonstrates substantial cost savings in addition to improved patient outcomes
Retrieved on:
Wednesday, June 14, 2023
Online, CT, Communication, Neuroradiology, Government, PMID, CBCT, Workflow, Vall, Stroke, 3D, Operation of computed tomography, Cone beam computed tomography, Ambulance, Journal of NeuroInterventional Surgery, Brain, Google Images, Trial of the century, NYSE, United States National Library of Medicine, EUR, MRI, X-ray, Philips, Triage, Journal, Patient, Intraparenchymal hemorrhage, AEX, Ultra, Diagnosis, PHG, LVO, Pharmaceutical industry, Medical imaging, Dietary supplement
Earlier results from this study demonstrated that a ‘Direct-to-Angio Suite’ (DTAS) pathway improves clinical outcomes for patients who have suffered a stroke.
Key Points:
- Earlier results from this study demonstrated that a ‘Direct-to-Angio Suite’ (DTAS) pathway improves clinical outcomes for patients who have suffered a stroke.
- “The ANGIOCAT clinical study has already shown that bringing stroke patients directly to the angio suite improves patient outcomes.
- For stroke centers, a time-saving alternative is to have a dedicated angio-suite permanently on standby, to which stroke patients can be transferred immediately after admission.
- Philips’ stroke portfolio includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessment, diagnostic imaging and analysis, image-guided therapy, neurological monitoring and assessment, and more.